Navigation Links
AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
Date:10/29/2008

Alliance extended for a further five years

WILMINGTON, Del. and HOUSTON, Oct. 29 /PRNewswire/ -- AstraZeneca and The University of Texas M. D. Anderson Cancer Center today announced they have renewed their collaboration to integrate pre-clinical and clinical research with a view to speeding up access to new medicines of potential benefit to cancer patients.

The collaboration facilitates interactions between physicians and scientists in both organizations to combine resources and expertise in disease intervention whilst providing flexibility to work in a variety of ways and accelerate the development of new treatments. It is unusual in its focus on pre-clinical research and the transition to clinical trials and was the first of its kind for both institutions.

Since its launch in 2005, the collaboration has utilized AstraZeneca's early development portfolio to generate over two dozen joint research projects. Both parties intend to build on these by extending the collaboration for a further five years and broadening its original focus from aerodigestive diseases (head and neck cancers and lung cancer) to include targets with potential in a variety of cancer settings.(1)

Brent Vose, Vice President of AstraZeneca's Oncology Therapy Area said: "AstraZeneca is committed to the research and development of new, targeted anti-cancer therapies to improve the lives of cancer patients.

"We have a number of promising compounds in development and look forward to seeing the results of some key studies throughout the next year.

"Our collaboration with M.D. Anderson has proven our ability to speed up the drug development process without compromising quality and we look forward to building on our joint efforts to date."

Close cooperation in areas of common interest is essential to meet the challenge of safe, accelerated drug development according to Robert C. Bast Jr., M.D., Vice President for Translational Research
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
2. Melior Enters Research Collaboration with AstraZeneca
3. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
4. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
5. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
6. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
7. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
8. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
9. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
10. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
11. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 The ... (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & ... and studies the Major Market Drivers, Restraints, and Opportunities in ... , Asia-Pacific and Rest of World. ... Tables 22 Figures ...
(Date:6/18/2013)... 2013 Research and ... addition of the report " DNA Sequencing ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... of human genome variations, development of sequencing ... small sequencers are described as well as ...
(Date:6/18/2013)... 18, 2013 ... has announced the addition of the ... Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, ... [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) ... to their offering.      ...
(Date:6/18/2013)... PathoGenetix, Inc. , a ... bacterial strain typing, announced today that John A. ... Vice President of Engineering. Dr. Luckey will lead ... RESOLUTION™ Microbial Genotyping System . The fully automated ... assay kits, database and software, will be commercially ...
Breaking Biology Technology:Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3
... are stunning. Others are not mismatched fonts, poorly aligned ... deluge of data presents a challenge to amateur designers, often ... figure,s main message. A group of University of Washington researchers ... those in design. The new Design Help Desk, similar to ...
... University have discovered a way to make a low-cost material ... a goal first theorized in 1861 by a giant ... wide practical use. Other materials can do this but ... way that yields the same result will have extraordinary possibilities, ...
... - February 23, 2012 Engineers at Harvard have demonstrated ... nanoantennas to obtain precise control of color output. Whereas ... a single active filter under exposure to different types of ... has the potential for application in televisions and biological imaging, ...
Cached Biology Technology:Design eye for the science guy: Drop-in clinic helps scientists communicate data 2Design eye for the science guy: Drop-in clinic helps scientists communicate data 3Discovery opens door to low-cost 'negative refraction,' new products and industries 2Metal nanoparticles shine with customizable color 2
(Date:6/18/2013)... At Brandeis University, sophisticated computational models and advances ... the complex interplay between genomic data, virus structure ... critical for replication. , "We ... will help researchers alter virus assembly, leaving viruses ... first author of the scientific paper describing the ...
(Date:6/18/2013)... Washington, D.C. June 18, 2013 Joshua Obar, ... UniversityBozeman, has been honored with a 2013 ICAAC Young ... the regulation of immunological memory responses to infection. ... Wesleyan University in 2001 and went on to complete ... in 2006. He performed his Ph.D. thesis research ...
(Date:6/18/2013)... to a chemical modification of DNA and this ... the DNA sequence. Until now, scientists believed that ... certain genes. Today, a team of researchers from ... Emmanouil Dermitzakis, Louis-Jeantet Professor at the Faculty of ... case and that DNA methylation may play both ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... of Alberta researchers has created technology to regrow teeth--the ... dental tissue. , Using low-intensity pulsed ultrasound (LIPUS), Dr. ... and Dr. Jie Chen and Dr. Ying Tsui from ... that offers a non-invasive and novel way to stimulate ...
... COX-2 enzymes may be blocked by pain medications such ... than was previously understood, a Queen's University study has ... implications for how we classify the commonly used anti-inflammatory ... Colin Funk, a professor of Biochemistry and Physiology at ...
... Noel Dahl and Mohammad F. Islam have made a ... disease that accelerates the aging process by about seven ... of chemical and biomedical engineering at Carnegie Mellon, said ... of the National Institutes of Health (NIH), the John ...
Cached Biology News:Ultrasound may help regrow teeth 2New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds 2Carnegie Mellon researchers discover new cell properties 2
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
Rabbit polyclonal to 3-Ethynylestradiol ( Abpromise for all tested applications). Antigen: Ethynylestradiol conjugated to BSA....
Antibody specific for histone H3 acetylated at any of the five N-terminal lysine residues. Rabbit polyclonal serum. Antigen: Synthetic peptide derived from histone H3 N-terminal region, mulitpliy...
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: